Perrigo Company (PRGO) Stock Forecast, Price Target & Predictions
PRGO Stock Forecast
Perrigo Company stock forecast is as follows: an average price target of $42.00 (represents a 54.70% upside from PRGO’s last price of $27.15) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
PRGO Price Target
PRGO Analyst Ratings
Hold
Perrigo Company Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 23, 2024 | Keith Devas | Jefferies | $30.00 | $27.06 | 10.86% | 10.50% |
Jun 13, 2024 | Korinne Wolmeyer | Piper Sandler | $36.00 | $27.84 | 29.31% | 32.60% |
Apr 08, 2024 | Korinne Wolmeyer | Piper Sandler | $39.00 | $31.40 | 24.20% | 43.65% |
Nov 17, 2023 | Korinne Wolfmeyer | Piper Sandler | $37.00 | $30.07 | 23.04% | 36.28% |
Sep 06, 2022 | Jacob Hughes | Wells Fargo | $54.00 | $36.74 | 46.98% | 98.90% |
May 04, 2022 | - | Raymond James | $48.00 | $32.76 | 46.54% | 76.80% |
10
Perrigo Company Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $30.00 | $35.00 |
Last Closing Price | $27.15 | $27.15 | $27.15 |
Upside/Downside | -100.00% | 10.50% | 28.91% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Apr 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 03, 2022 | Raymond James | Outperform | Outperform | Hold |
Sep 14, 2022 | Bernstein | - | Market Perform | Downgrade |
Sep 14, 2022 | Guggenheim | - | Neutral | Downgrade |
Sep 14, 2022 | B. Riley Securities | - | Buy | Initialise |
Sep 14, 2022 | Morgan Stanley | - | Equal-Weight | Downgrade |
Sep 14, 2022 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
Sep 14, 2022 | Jefferies | - | Hold | Downgrade |
Sep 14, 2022 | Argus Research | - | Buy | Upgrade |
10
Perrigo Company Financial Forecast
Perrigo Company Revenue Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.16B | $1.12B | $1.19B | $1.18B | $1.16B | $1.10B | $1.12B | $1.07B | $1.10B | $1.04B | $981.10M | $1.01B | $1.29B | $1.21B |
Avg Forecast | $1.35B | $1.21B | $1.18B | $1.22B | $1.29B | $1.15B | $1.14B | $1.15B | $1.24B | $1.12B | $1.12B | $1.13B | $1.20B | $1.12B | $1.10B | $1.09B | $1.17B | $1.20B | $1.18B | $1.17B | $1.20B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B |
High Forecast | $1.37B | $1.22B | $1.19B | $1.23B | $1.30B | $1.16B | $1.15B | $1.17B | $1.25B | $1.13B | $1.13B | $1.14B | $1.22B | $1.13B | $1.11B | $1.09B | $1.20B | $1.20B | $1.19B | $1.18B | $1.21B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B |
Low Forecast | $1.34B | $1.20B | $1.17B | $1.20B | $1.27B | $1.14B | $1.12B | $1.14B | $1.23B | $1.11B | $1.11B | $1.12B | $1.18B | $1.12B | $1.08B | $1.09B | $1.14B | $1.20B | $1.17B | $1.16B | $1.19B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 0.94% | 1.01% | 1.01% | 0.96% | 0.96% | 1.05% | 1.02% | 1.01% | 0.99% | 0.96% | 0.99% | 0.98% | 0.98% |
Forecast
Perrigo Company EBITDA Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-15.50M | $184.10M | $56.80M | $140.10M | $134.00M | $144.70M | $32.30M | $95.90M | $91.30M | $488.30M | $3.60M | $174.70M | $-80.70M | $3.20M |
Avg Forecast | $197.93M | $177.27M | $173.00M | $178.20M | $188.07M | $168.61M | $166.26M | $168.94M | $181.79M | $164.32M | $163.79M | $165.14M | $175.79M | $164.13M | $160.67M | $154.10M | $171.87M | $175.60M | $172.75M | $140.09M | $76.39M | $213.88M | $199.42M | $110.74M | $205.91M | $196.97M | $190.64M | $196.15M | $246.97M | $231.42M |
High Forecast | $199.78M | $178.94M | $174.62M | $179.87M | $189.83M | $170.19M | $167.81M | $170.52M | $183.50M | $165.86M | $165.32M | $166.68M | $178.72M | $165.03M | $162.66M | $184.92M | $176.20M | $175.80M | $174.37M | $168.11M | $91.66M | $213.88M | $199.42M | $132.89M | $205.91M | $196.97M | $190.64M | $235.39M | $246.97M | $231.42M |
Low Forecast | $195.76M | $175.33M | $171.11M | $176.24M | $186.01M | $166.77M | $164.44M | $167.09M | $179.80M | $162.52M | $161.99M | $163.33M | $172.86M | $163.23M | $158.69M | $123.28M | $166.09M | $175.41M | $170.86M | $112.07M | $61.11M | $213.88M | $199.42M | $88.59M | $205.91M | $196.97M | $190.64M | $156.92M | $246.97M | $231.42M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.09% | 1.05% | 0.33% | 1.00% | 1.75% | 0.68% | 0.16% | 0.87% | 0.44% | 2.48% | 0.02% | 0.89% | -0.33% | 0.01% |
Forecast
Perrigo Company Net Income Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-32.30M | $14.20M | $8.40M | $-1.10M | $-12.70M | $-52.10M | $-64.90M | $-1.30M | $32.10M | $-53.90M | $-111.90M | $2.80M | $-175.00M | $-154.60M |
Avg Forecast | $134.75M | $123.75M | $119.63M | $121.00M | $134.69M | $111.83M | $106.42M | $106.88M | $126.24M | $101.82M | $97.95M | $96.87M | $130.28M | $111.58M | $65.12M | $-4.06M | $114.13M | $86.12M | $70.29M | $-3.69M | $-21.10M | $91.61M | $60.32M | $-2.91M | $77.23M | $89.57M | $81.92M | $42.78M | $137.44M | $115.34M |
High Forecast | $136.39M | $125.26M | $121.08M | $122.47M | $136.33M | $113.19M | $107.71M | $108.18M | $127.78M | $103.06M | $99.15M | $102.41M | $134.53M | $113.54M | $66.20M | $-3.24M | $116.88M | $87.04M | $71.15M | $-2.95M | $-16.88M | $91.61M | $60.32M | $-2.33M | $77.23M | $89.57M | $81.92M | $51.33M | $137.44M | $115.34M |
Low Forecast | $132.83M | $121.99M | $117.92M | $119.28M | $132.77M | $110.24M | $104.90M | $105.36M | $124.44M | $100.37M | $96.56M | $91.34M | $126.03M | $109.62M | $64.05M | $-4.87M | $107.25M | $85.21M | $69.29M | $-4.42M | $-25.31M | $91.61M | $60.32M | $-3.50M | $77.23M | $89.57M | $81.92M | $34.22M | $137.44M | $115.34M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.28% | 0.16% | 0.12% | 0.30% | 0.60% | -0.57% | -1.08% | 0.45% | 0.42% | -0.60% | -1.37% | 0.07% | -1.27% | -1.34% |
Forecast
Perrigo Company SG&A Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $152.50M | $304.00M | $171.10M | $331.50M | $308.60M | $281.00M | $338.10M | $282.30M | $269.30M | $283.60M | $274.30M | $284.20M | $330.00M | $281.00M |
Avg Forecast | $348.39M | $312.03M | $304.51M | $313.66M | $331.04M | $296.79M | $292.64M | $297.36M | $319.99M | $289.23M | $288.29M | $290.67M | $309.42M | $288.89M | $282.81M | $477.00M | $302.52M | $309.09M | $304.08M | $433.63M | $320.43M | $294.02M | $274.14M | $342.79M | $283.06M | $270.77M | $262.08M | $319.10M | $339.51M | $318.12M |
High Forecast | $351.65M | $314.96M | $307.37M | $316.59M | $334.14M | $299.57M | $295.38M | $300.15M | $322.99M | $291.94M | $290.99M | $293.39M | $314.58M | $290.48M | $286.31M | $572.40M | $310.14M | $309.43M | $306.92M | $520.36M | $384.51M | $294.02M | $274.14M | $411.35M | $283.06M | $270.77M | $262.08M | $382.92M | $339.51M | $318.12M |
Low Forecast | $344.57M | $308.62M | $301.18M | $310.22M | $327.41M | $293.54M | $289.43M | $294.11M | $316.48M | $286.06M | $285.13M | $287.49M | $304.27M | $287.31M | $279.31M | $381.60M | $292.35M | $308.75M | $300.74M | $346.91M | $256.34M | $294.02M | $274.14M | $274.23M | $283.06M | $270.77M | $262.08M | $255.28M | $339.51M | $318.12M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.50% | 0.98% | 0.56% | 0.76% | 0.96% | 0.96% | 1.23% | 0.82% | 0.95% | 1.05% | 1.05% | 0.89% | 0.97% | 0.88% |
Forecast
Perrigo Company EPS Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.24 | $0.10 | $0.06 | $-0.01 | $-0.09 | $-0.39 | $-0.48 | $-0.01 | $0.24 | $-0.40 | $-0.84 | $0.29 | $-1.29 | $-1.13 |
Avg Forecast | $0.98 | $0.90 | $0.87 | $0.88 | $0.98 | $0.81 | $0.77 | $0.78 | $0.92 | $0.74 | $0.71 | $0.70 | $0.95 | $0.81 | $0.47 | $0.23 | $0.83 | $0.63 | $0.51 | $0.43 | $0.70 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 |
High Forecast | $0.99 | $0.91 | $0.88 | $0.89 | $0.99 | $0.82 | $0.78 | $0.79 | $0.93 | $0.75 | $0.72 | $0.74 | $0.98 | $0.83 | $0.48 | $0.24 | $0.85 | $0.63 | $0.52 | $0.44 | $0.71 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 |
Low Forecast | $0.97 | $0.89 | $0.86 | $0.87 | $0.97 | $0.80 | $0.76 | $0.77 | $0.91 | $0.73 | $0.70 | $0.66 | $0.92 | $0.80 | $0.47 | $0.23 | $0.78 | $0.62 | $0.50 | $0.42 | $0.69 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.29% | 0.16% | 0.12% | -0.02% | -0.13% | -0.58% | -1.09% | -0.02% | 0.43% | -0.61% | -1.41% | 0.51% | -1.29% | -1.34% |
Forecast
Perrigo Company Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
KMDA | Kamada | $5.82 | $20.00 | 243.64% | - |
PCRX | Pacira BioSciences | $17.03 | $35.00 | 105.52% | Hold |
ELAN | Elanco Animal Health | $13.44 | $26.50 | 97.17% | Buy |
PRGO | Perrigo Company | $27.15 | $42.00 | 54.70% | Hold |
AMPH | Amphastar Pharmaceuticals | $44.09 | $66.00 | 49.69% | Buy |
ANIP | ANI Pharmaceuticals | $55.10 | $79.00 | 43.38% | Buy |
COLL | Collegium Pharmaceutical | $30.00 | $40.50 | 35.00% | Buy |
PBH | Prestige Consumer Healthcare | $82.67 | $89.50 | 8.26% | Buy |
DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
PAHC | Phibro Animal Health | $23.39 | $18.67 | -20.18% | Buy |